N
Nora D. Volkow
Researcher at National Institute on Drug Abuse
Publications - 1038
Citations - 121498
Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.
Papers
More filters
Journal ArticleDOI
Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors.
S. John Gatley,Ruoxi Lan,Beatrice Pyatt,Andrew N. Gifford,Nora D. Volkow,Alexandros Makriyannis +5 more
TL;DR: In vitro autoradiography demonstrated that the distribution of binding sites for [123I]AM251 in rat brain was very similar to published distributions of binding Sites for [3H]CP 55,940, suggesting that AM251 binds to the same site (the cannabinoid CB1 receptor) in rodent brains as CP55,940.
Journal ArticleDOI
Translating Glutamate: From Pathophysiology to Treatment
Daniel C. Javitt,Darryle D. Schoepp,Peter W. Kalivas,Nora D. Volkow,Carlos A. Zarate,Kalpana M. Merchant,Mark F. Bear,Daniel Umbricht,Mihály Hajós,William Z. Potter,Chi-Ming Lee +10 more
TL;DR: A recent Institute of Medicine–sponsored meeting is reviewed, highlighting advances in glutamatergic theories of neuropsychiatric illness as well as remaining barriers to treatment development.
Journal ArticleDOI
Laterality Patterns of Brain Functional Connectivity: Gender Effects
TL;DR: The laterality patterns of short-range and long-range functional connectivity and the gender effects on theseLaterality patterns are studied and it is found that males had greater rightward lateralization of brain connectivity in superior temporal, inferior frontal, and inferior occipital cortices (short-range), whereas females had greater leftward lateralized of long- range connectivity in the inferior frontal cortex.
Journal ArticleDOI
Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors.
TL;DR: The results demonstrate that the cannabinoid CB1 receptor is an essential component of the molecular pathways underlying the reinforcing effects of alcohol, and medications targeting the CB1 receptors may be beneficial for the treatment of alcoholism.
Journal ArticleDOI
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
Nora D. Volkow,Nora D. Volkow,Gene-Jack Wang,Joanna S. Fowler,Jean Logan,Samuel J. Gatley,Robert R. MacGregor,David J. Schlyer,Robert Hitzemann,Alfred P. Wolf +9 more
TL;DR: Findings of correlational analysis between age and dopamine D2 receptor availability were significant for both ligand and both ligands documented significant age-related decreases in dopamine D 2 receptors that occurred relatively early in life.